During the past decade, NECCR Primacare Research, LLC conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 15 clinical trials were completed, i.e. on average, 40.5% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 13 clinical trials were completed. i.e. 65% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NECCR Primacare Research, LLC" #1 sponsor was "Eli Lilly and Company" with 14 trials, followed by "Gen-Probe, Incorporated" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Emotional Brain NY Inc." with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NECCR Primacare Research, LLC" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "NECCR Primacare Research, LLC" are "Type 2 Diabetes" (4 trials), "Migraine, With or Without Aura" (3 trials), "Obesity" (3 trials), "Overweight" (3 trials) and "Chlamydia Trachomatis" (2 trials). Many other conditions were trialed in "NECCR Primacare Research, LLC" in a lesser frequency.

Most popular intervention types in "NECCR Primacare Research, LLC" are "Drug" (33 trials), "Device" (8 trials), "Other" (6 trials), "Diagnostic Test" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Tirzepatide" (6 trials), "Rimegepant" (3 trials), "BMS-986036" (2 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "NECCR Primacare Research, LLC" are 38 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "NECCR Primacare Research, LLC". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in NECCR Primacare Research, LLC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in NECCR Primacare Research, LLC, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".